Logo
x

Search category

Subscribe Now

emperial studies

Boehringer Ingelheim and Lilly Report Results of Jardiance (empagliflozin) in P-III EMPERIAL Studies for Chronic Heart Failure

Boehringer Ingelheim and Lilly Report Results of Jardiance (empagliflozin) in P-III EMPERIAL Studies for Chronic Heart Failure

  • December 16, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.